Caplin Point Laboratories informs about quarterly statement on investor complaints

06 Jan 2017 Evaluate

Caplin Point Laboratories has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

1735.00 0.25 (0.01%)
23-Jan-2026 10:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1630.40
Dr. Reddys Lab 1245.90
Cipla 1380.55
Zydus Lifesciences 889.60
Lupin 2151.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×